Avacta Group (LON:AVCT) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Avacta Group Plc (LON:AVCT) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 67.74 and traded as high as GBX 89. Avacta Group shares last traded at GBX 86.50, with a volume of 1,165,299 shares.

Avacta Group Price Performance

The firm has a market capitalization of £392.28 million, a price-to-earnings ratio of -4.93 and a beta of 1.12. The company has a quick ratio of 4.96, a current ratio of 0.79 and a debt-to-equity ratio of 14,168.75. The company’s fifty day moving average is GBX 72.31 and its two-hundred day moving average is GBX 67.74.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).